AGY vs HIK: Side-by-Side Comparison
Compare Allergy Therapeutics (AGY) and Hikma Pharmaceuticals PLC (HIK) side by side: market cap GBX 44.96B vs GBX 3.30B. Financials, growth and model signals on Bullrun.
| Metric | AGY | HIK |
|---|---|---|
| Company | Allergy Therapeutics | Hikma Pharmaceuticals PLC |
| Country / Exchange | United Kingdom · LSE | United Kingdom · LSE |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic |
| Market cap | GBX 44.96B | GBX 3.30B |
| P/E ratio | — | 11.5 |
| Dividend yield | — | 4.04% |
| Valuation model | — | — |
| Revenue (FY2025) | GBP 55.04M | GBP 3.35B |
| Revenue growth YoY | -0.3% | +7.1% |
| Net income | GBP -40.13M | GBP 402.00M |
| Gross margin | 53.2% | 43.0% |
| Diluted EPS | -0.01 | 1.81 |